Fig. 1From: Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC)Representative images of PD-L1 expression and CD8+ tumor infiltrating lymphocytes (TILs) in patients with small cell lung cancer (SCLC), as determined by immunohistochemistry (IHC). The first line 100× magnification. The second line 400× magnificationBack to article page